Company: SONM
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001493152-25-016055
Chunk: 11

Company: SONIM TECHNOLOGIES INC
Filing Date: 2025-09-29
Form: S-1
Chunk 11
---
 of proceeds                                  |     | We                                                                                                                                      
 will not receive any proceeds from the resale of shares of our Common Stock by Chardan. However, we may receive up to $500.0 million    
 in aggregate gross proceeds from Chardan under the Purchase Agreement in connection with sales of shares of our Common Stock to Chardan 
 pursuant to the Purchase Agreement from time to time after the date of this prospectus. However, the actual proceeds we                 
 receive may be less than this amount (before being reduced for the discount to Chardan) depending on the number of shares               
 of our Common Stock sold and the price at which the shares of our Common Stock are sold. A minimum of thirty-three percent (33%)        
 of such proceeds will be applied to the pre-payment of the July Note, pursuant to the terms of the July Note. The Company intends       
 to use any remaining proceeds for our operations, to support our overall business strategy, for working capital purposes, and for       
 general corporate purposes, which may include repayment and refinancing of our indebtedness. Pending other uses, we intend to invest    
 the net proceeds to us in investment-grade, interest-bearing securities such as money market funds, certificates of deposit, or direct  
 or guaranteed obligations of the U.S. government, or hold as cash. We cannot predict whether the net proceeds invested will yield       
 a favorable return. See “Use of Proceeds.”                                                                                              |
| Conflicts of Interest                            |     | Chardan is a member of the Financial Industry Regulatory                                                                                
 Authority, Inc. (“FINRA”) and is expected to act as an executing broker for the resale of shares of our Common Stock                    
 in this offering. The receipt by Chardan of all the proceeds from resales of shares of our Common Stock results in a “conflict          
 of interest” under FINRA Rule 5121. Accordingly, such resales will be conducted in compliance with FINRA Rule 5121. To the              
 extent that the shares of our Common Stock do not have a “bona fide public market”, as defined in FINRA Rule 5121, a                    
 qualified independent underwriter will participate in the preparation of, and exercise the usual standards of “due diligence”           
 with respect to, the registration statement. Pursuant to FINRA Rule 5121, Chardan will not confirm resales of shares                    
 of our Common Stock to any account over which it exercises discretionary authority without the prior written approval of the customer.  
 See “Plan of Distribution (